Back to search

Molecule Structure

Scientific Name


Description of the Drug

Trilaciclib is a CDK4 and CDK6 inhibitor to reduce the risk of chemotherapy induced myelosuppression.

Source: DrugBank Online – Retrieved 2023-03-10 from

Brand Name(s)

Not Available

Company Owner(s)

G1 Therapeutics Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Cyclin-dependent kinase 6 SINGLE PROTEIN INHIBITOR CHEMBL2508
Cyclin-dependent kinase 4 SINGLE PROTEIN INHIBITOR CHEMBL331

Unichem Links

SureChEMBL SCHEMBL10082028
Human Metabolome Database HMDB0304899
DrugBank DB15442
PubChem 68029831
BindingDB 253928
DrugCentral 5442
ChemicalBook CB73353991
Guide to Pharmacology 9626